Cargando…

A concordant expression pattern of fatty acid synthase and membranous human epidermal growth factor receptor 2 exists in gastric cancer and is associated with a poor prognosis in gastric adenocarcinoma patients

Fatty acid synthase (FAS) and human epidermal growth factor receptor 2 (HER2) are overexpressed in gastric cancer (GC), and certain interactions have been found between FAS and HER2. A total of 94 patients were enrolled in the present study, each of whom underwent a D2 radical surgery in Zhongshan H...

Descripción completa

Detalles Bibliográficos
Autores principales:	LI, HE, WANG, XUEFEI, TANG, ZHAOQING, LIU, FENGLIN, CHEN, WEIDONG, FANG, YONG, WANG, CONG, SHEN, KUNTANG, QIN, JING, SHEN, ZHENBIN, SUN, YIHONG, QIN, XINYU
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4579914/ https://www.ncbi.nlm.nih.gov/pubmed/26622804 http://dx.doi.org/10.3892/ol.2015.3609

Ejemplares similares

Expanded endoscopic therapy criteria should be cautiously used in intramucosal gastric cancer
por: Wang, Hongshan, et al.
Publicado: (2016)

The IGCA staging system is more accurate than AJCC7 system in stratifying survival of patients with gastric cancer in stage III
por: Shu, Ping, et al.
Publicado: (2017)

Upregulated Expression of C-X-C Chemokine Receptor 4 Is an Independent Prognostic Predictor for Patients with Gastric Cancer
por: He, Hongyong, et al.
Publicado: (2013)

Increased expression of IDO associates with poor postoperative clinical outcome of patients with gastric adenocarcinoma
por: Liu, Hao, et al.
Publicado: (2016)

Pattern of No. 12a lymph node metastasis in gastric cancer
por: Shu, Ping, et al.
Publicado: (2021)

Increased Expression of CSF-1 Associates With Poor Prognosis of Patients With Gastric Cancer Undergoing Gastrectomy
por: Liu, Hao, et al.
Publicado: (2016)

Tumor size and perineural invasion predict outcome of gastric high-grade neuroendocrine neoplasms
por: Zhang, Qi, et al.
Publicado: (2021)

The prognostic value of CXC-chemokine receptor 2 (CXCR2) in gastric cancer patients
por: Wang, Zhenglin, et al.
Publicado: (2015)

Prognostic value of stromal cell-derived factor 1 expression in patients with gastric cancer after surgical resection
por: Wang, Xuefei, et al.
Publicado: (2014)

Neoadjuvant apatinib combined with oxaliplatin and capecitabine in patients with locally advanced adenocarcinoma of stomach or gastroesophageal junction: a single-arm, open-label, phase 2 trial
por: Tang, Zhaoqing, et al.
Publicado: (2022)

Interleukin-13 receptor α2 is associated with poor prognosis in patients with gastric cancer after gastrectomy
por: Lin, Chao, et al.
Publicado: (2016)

Oxaliplatin plus Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Adenocarcinoma in Combination with D2 Gastrectomy: NEO‐CLASSIC Study
por: Yu, Yiyi, et al.
Publicado: (2019)

High expression of eIF3d is associated with poor prognosis in patients with gastric cancer
por: He, Jiaqi, et al.
Publicado: (2017)

The Role of Prion Protein Expression in Predicting Gastric Cancer Prognosis
por: Tang, Zhaoqing, et al.
Publicado: (2016)

RNA m(5)C regulator-mediated modification patterns and the cross-talk between tumor microenvironment infiltration in gastric cancer
por: Zhang, Qiang, et al.
Publicado: (2022)

High Intratumoral Expression of Tetranectin Associates with Poor Prognosis of Patients with Gastric Cancer after Gastrectomy
por: Chen, Hao, et al.
Publicado: (2017)

Integrated Analysis of Stemness-Related LncRNAs Helps Predict the Immunotherapy Responsiveness of Gastric Cancer Patients
por: Jiang, Quan, et al.
Publicado: (2021)

Decreased expression of granulocyte-macrophage colony-stimulating factor is associated with adverse clinical outcome in patients with gastric cancer undergoing gastrectomy
por: Liu, Hao, et al.
Publicado: (2017)

Stemness-related LncRNA pair signature for predicting therapy response in gastric cancer
por: Jiang, Quan, et al.
Publicado: (2021)

High overexpression of fatty acid synthase is associated with poor survival in Chinese patients with gastric carcinoma
por: HOU, WENMIN, et al.
Publicado: (2012)

Outcomes of gastrectomy following upfront chemotherapy in advanced gastric cancer patients with a single noncurable factor: a cohort study
por: Li, Wei, et al.
Publicado: (2019)

Does resection after neoadjuvant chemotherapy of docetaxel, oxaliplatin, and S-1 (DOS regimen) benefit for gastric cancer patients with single non-curable factor? a multicenter, prospective cohort study (Neo-REGATTA)
por: Cui, Yuehong, et al.
Publicado: (2023)

Establishment of an Immune Cell Infiltration Score to Help Predict the Prognosis and Chemotherapy Responsiveness of Gastric Cancer Patients
por: Jiang, Quan, et al.
Publicado: (2021)

The Neo-PLANET phase II trial of neoadjuvant camrelizumab plus concurrent chemoradiotherapy in locally advanced adenocarcinoma of stomach or gastroesophageal junction
por: Tang, Zhaoqing, et al.
Publicado: (2022)

Decreased expression of STING predicts poor prognosis in patients with gastric cancer
por: Song, Shushu, et al.
Publicado: (2017)

Role of surgery in patients with focally progressive gastrointestinal stromal tumors resistant to imatinib
por: Gao, Xiaodong, et al.
Publicado: (2016)

RACK1 overexpression is linked to acquired imatinib resistance in gastrointestinal stromal tumor
por: Gao, Xiaodong, et al.
Publicado: (2016)

Overexpression of fatty acid synthase predicts a poor prognosis for human gastric cancer
por: DUAN, JIANGMAN, et al.
Publicado: (2016)

High expression of ceramide synthase 5 predicts a poor prognosis in gastric cancer
por: Zhang, Shengjie, et al.
Publicado: (2022)

Multiplex immune profiling reveals the role of serum immune proteomics in predicting response to preoperative chemotherapy of gastric cancer
por: Tang, Zhaoqing, et al.
Publicado: (2023)

Discovery of Non-invasive Glycan Biomarkers for Detection and Surveillance of Gastric Cancer
por: Qin, Ruihuan, et al.
Publicado: (2017)

Heterogeneity response to afatinib in gastric cancer patient with uncommon epidermal growth factor receptor (EGFR) mutations: a case report
por: Liu, Qin, et al.
Publicado: (2021)

A nomogram based on glycomic biomarkers in serum and clinicopathological characteristics for evaluating the risk of peritoneal metastasis in gastric cancer
por: Zhao, Junjie, et al.
Publicado: (2020)

NOTCH3 is a Prognostic Factor and Is Correlated With Immune Tolerance in Gastric Cancer
por: Cui, Yuehong, et al.
Publicado: (2021)

PLOD3 contributes to HER-2 therapy resistance in gastric cancer through FoxO3/Survivin pathway
por: Chen, Yueda, et al.
Publicado: (2022)

High Hepsin expression predicts poor prognosis in Gastric Cancer
por: Zhang, Mingming, et al.
Publicado: (2016)

The significance of the co-existence of osteopontin and tumor-associated macrophages in gastric cancer progression
por: Lin, Chang-Ni, et al.
Publicado: (2015)

High GP73 Expression Correlates with Poor Response to Neoadjuvant Chemotherapy and Survival in Gastric Cancer: A Tissue Microarray Study
por: Shen, Jian Guo, et al.
Publicado: (2021)

Cancer cells invasion to the gastric bare area adipose tissue: a poor prognostic predictor for gastric cancer
por: Chen, Yongming, et al.
Publicado: (2020)

G3BP1 interacts with YWHAZ to regulate chemoresistance and predict adjuvant chemotherapy benefit in gastric cancer
por: Zhao, Junjie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6gvno6d2ur2hguvjacefhjjcm8